[go: up one dir, main page]

EE200800063A - N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine - Google Patents

N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine

Info

Publication number
EE200800063A
EE200800063A EEP200800063A EEP200800063A EE200800063A EE 200800063 A EE200800063 A EE 200800063A EE P200800063 A EEP200800063 A EE P200800063A EE P200800063 A EEP200800063 A EE P200800063A EE 200800063 A EE200800063 A EE 200800063A
Authority
EE
Estonia
Prior art keywords
pyrrolidinone
phenyl
carbamoylmethyl
preparation
pharmaceutical use
Prior art date
Application number
EEP200800063A
Other languages
English (en)
Inventor
Veinberg Grigory
Vorona Maksim
Zvejniece Liga
Chernobrovijs Aleksandrs
Kalvinsh Ivars
Karina Ligita
Dambrova Maija
Original Assignee
Akciju Sabiedriba ''olainfarm''
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akciju Sabiedriba ''olainfarm'' filed Critical Akciju Sabiedriba ''olainfarm''
Publication of EE200800063A publication Critical patent/EE200800063A/et
Publication of EE05536B1 publication Critical patent/EE05536B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
EEP200800063A 2006-03-16 2007-03-15 N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine EE05536B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-06-45A LV13630B (en) 2006-03-16 2006-03-16 Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
PCT/EP2007/052424 WO2007104780A2 (en) 2006-03-16 2007-03-15 N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use

Publications (2)

Publication Number Publication Date
EE200800063A true EE200800063A (et) 2008-12-15
EE05536B1 EE05536B1 (et) 2012-04-16

Family

ID=38461010

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200800063A EE05536B1 (et) 2006-03-16 2007-03-15 N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine

Country Status (21)

Country Link
US (2) US9102615B2 (et)
EP (1) EP2013166B1 (et)
CN (1) CN101448786A (et)
AT (1) ATE460396T1 (et)
CA (1) CA2647206C (et)
CY (1) CY1110170T1 (et)
DE (1) DE602007005244D1 (et)
DK (1) DK2013166T3 (et)
EA (1) EA014668B1 (et)
EE (1) EE05536B1 (et)
ES (1) ES2342024T3 (et)
GE (1) GEP20104915B (et)
HR (1) HRP20090524C1 (et)
LT (1) LT5589B (et)
LV (1) LV13630B (et)
ME (1) ME01192B (et)
PL (1) PL2013166T3 (et)
PT (1) PT2013166E (et)
SI (1) SI2013166T1 (et)
UA (1) UA96440C2 (et)
WO (1) WO2007104780A2 (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2392915C1 (ru) * 2009-04-14 2010-06-27 Федеральное государственное учреждение "Новокузнецкий научно-практический центр медико-социальной экспертизы и реабилитации инвалидов Федерального агентства по здравоохранению и социальному развитию" (ФГУ ННПЦ МСЭ и РИ Росздрава) Способ формирования двигательных функций у инвалидов с позвоночно-спинно-мозговой травмой
LV14346B (lv) * 2009-11-05 2011-07-20 Grindeks, A/S 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti
RU2437659C1 (ru) * 2010-11-12 2011-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный педагогический университет им. А.И. Герцена" (РГПУ им. А.И. Герцена) Средство, обладающее антидепрессивным, анксиолитическим и ноотропным действием
EP2694474A1 (en) * 2011-03-11 2014-02-12 Grindeks 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
RU2480214C1 (ru) 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов
ES2727474T3 (es) 2012-05-08 2019-10-16 Nicox Ophthalmics Inc Nanocristales de propionato de fluticasona
TW201408293A (zh) 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療疾病相關疲勞之用途
TW201408294A (zh) 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療帕金森氏症之用除
LV15003B (lv) * 2013-10-22 2015-08-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei
LV15015B (lv) 2013-12-13 2015-12-20 Olainfarm, A/S 3-karboksi-4-(R)-fenilpirolidin-2-ona sāls un tā pielietošana
LV15016B (lv) * 2013-12-18 2016-01-20 Olainfarm, A/S N-karbamoilmetil-4(R)-fenil-2-pirolidinona polimorfās formas
EP2891491A1 (en) 2014-01-03 2015-07-08 Merz Pharma GmbH & Co. KGaA Use of (r)-phenylpiracetam for the treatment of sleep disorders
LV15072B (lv) 2014-05-14 2016-09-20 Olainfarm, A/S Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai
EP3127539A1 (en) * 2015-08-03 2017-02-08 Latvian Institute Of Organic Synthesis Use of 2-(5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures
EP4582412A1 (en) * 2022-08-31 2025-07-09 Korea University Research and Business Foundation Chiral gamma lactam derivative or pharmaceutically acceptable salt thereof, and preparation method therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
RU2232578C1 (ru) * 2003-04-10 2004-07-20 Ахапкина Валентина Ивановна Вещество, обладающее антидепрессивной активностью
RU2289404C1 (ru) * 2005-04-06 2006-12-20 ГОУ ВПО "Московский государственный медико-стоматологический университет Министерства здравоохранения РФ" Способ премедикации у пациентов со средним уровнем психоэмоционального напряжения при амбулаторных стоматологических вмешательствах

Also Published As

Publication number Publication date
EA014668B1 (ru) 2010-12-30
US9382203B2 (en) 2016-07-05
US20100022784A1 (en) 2010-01-28
LT2008075A (en) 2009-06-25
LV13630B (en) 2007-12-20
PT2013166E (pt) 2010-06-09
EE05536B1 (et) 2012-04-16
CA2647206C (en) 2011-09-27
ATE460396T1 (de) 2010-03-15
US20150216846A1 (en) 2015-08-06
ME01192B (me) 2012-12-20
HRP20090524A2 (hr) 2009-12-31
UA96440C2 (ru) 2011-11-10
WO2007104780A3 (en) 2007-11-29
DK2013166T3 (da) 2010-07-05
LT5589B (lt) 2009-08-25
ES2342024T3 (es) 2010-06-30
CN101448786A (zh) 2009-06-03
EP2013166A2 (en) 2009-01-14
PL2013166T3 (pl) 2010-08-31
HRP20090524C1 (hr) 2017-03-10
CA2647206A1 (en) 2007-09-20
DE602007005244D1 (de) 2010-04-22
SI2013166T1 (sl) 2010-07-30
CY1110170T1 (el) 2015-01-14
EA200801978A1 (ru) 2009-04-28
GEP20104915B (en) 2010-03-10
HRPK20090524B3 (hr) 2012-12-31
EP2013166B1 (en) 2010-03-10
US9102615B2 (en) 2015-08-11
WO2007104780A2 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
EE200800063A (et) N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
MY149705A (en) Pyridino-pyridinone derivatives, preparation therof, and therapeutic use thereof
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
EA201071291A3 (ru) Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств
NO20081592L (no) Dipeptidylpeptidaseinhibitorer for behandling av diabetes
MA32568B1 (fr) Formulations pharmaceutiques contenant des ligands de recepteur de dopamine
EP1937766A4 (en) MODIFIED POLYAMIDES, USES THEREOF AND MANUFACTURING METHOD THEREFOR
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
CR20110042A (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo [1,4]dioxin-2-ilmetil)-sulfamida
MY151004A (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-?]imidazole-3-carboxylic acid amides
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
CY1116166T1 (el) Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori
UA107201C2 (uk) 4-[етил(диметил)амоній]бутаноат та його застосування в лікуванні серцево-судинної хвороби
WO2009024838A3 (en) Impression and model components
EA200870148A1 (ru) Производные сулиндака, их применение и получение
CY1109803T1 (el) Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση
NO20091386L (no) Fenyloksyanilinderivater
EA200701072A1 (ru) Препараты бензотиазола и их применение
EA200801211A1 (ru) Производные 9-хлор-15-простагландина, способ их получения и использования в лекарственных препаратах
EA200801977A1 (ru) Способ получения r-энантиомера n-карбамоилметил-4r-фенил-2-пирролидона
CL2009000317A1 (es) Compuestos derivados de 3-alquil-piperazina sustituida; composicion farmaceutica; y su uso en el tratamiento de la depresion y ansiedad.
UA34815U (ru) Способ коррекции цитокинового статуса больных острым тонзиллитом

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20210315